Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Drucker

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Cancer Genetics|February 7, 2018
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Sarah H Johnson, James B Smadbeck, Stephanie A Smoley, et al.
Skin Health and Disease|October 2, 2025
Harmonizing epidemiological research methodology for atopic dermatitis research: protocol for the EPISTAR international consensus exerciseSuzanne H Keddie, Karl Philipp Drewitz, Katrina Abuabara, et al.
JAMA Dermatology|January 16, 2020
Core Outcome Set for Actinic Keratosis Clinical TrialsKelly A Reynolds, Daniel I Schlessinger, Jelena Vasic, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
The British Journal of Dermatology|November 25, 2020
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomesK A Reynolds, D I Schlessinger, A F Yanes, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Cancer Genetics|February 7, 2018
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Sarah H Johnson, James B Smadbeck, Stephanie A Smoley, et al.
Skin Health and Disease|October 2, 2025
Harmonizing epidemiological research methodology for atopic dermatitis research: protocol for the EPISTAR international consensus exerciseSuzanne H Keddie, Karl Philipp Drewitz, Katrina Abuabara, et al.
JAMA Dermatology|January 16, 2020
Core Outcome Set for Actinic Keratosis Clinical TrialsKelly A Reynolds, Daniel I Schlessinger, Jelena Vasic, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Seminars in Arthritis and Rheumatism|January 28, 2024
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome SetWils Nielsen, Vibeke Strand, Lee S Simon, et al.
The British Journal of Dermatology|November 25, 2020
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomesK A Reynolds, D I Schlessinger, A F Yanes, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
Pageof 31